Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Testing Referral Rates for Pheochromocytoma and Paraganglioma in an Academic Tertiary Centre

15 Apr 2025

Abstract excerpt

BACKGROUND: Clinical guidelines recommend genetic counselling for all patients with pheochromocytoma or paraganglioma (PPGL). Barriers to accessing genetics evaluation are incompletely understood. The objective of this study was to identify individual- and provider-level barriers to genetic testing. METHODS: Retrospective study of patients with PPGL who underwent resection at a tertiary academic centre. Study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal and Paraganglionic Tumors
Share to Hormonal Regulation and Hypertension
Share to Pituitary Gland Disorders and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40235160
DOI: 10.1111/cen.15248

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Testing Referral Rates for Pheochromocytoma and Paraganglioma in an Academic Tertiary CentrePMID 40235160Read ↗

Trends of genetic screening in patients with pheochromocytoma and paraganglioma: 15-year experience in a high-volume tertiary referral center.Semantic proximity Read ↗

Genetic predisposition to pheochromocytoma and paraganglioma: 21 years of experience in the field.Semantic proximity Read ↗

Pheochromocytoma and paraganglioma: molecular testing and personalized medicine.Semantic proximity Read ↗

Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma.Semantic proximity Read ↗

Universal Germline Panel Testing for Individuals With Pheochromocytoma and Paraganglioma Produces High Diagnostic Yield.Semantic proximity Read ↗

Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.Semantic proximity Read ↗

Inherited Mutations in Pheochromocytoma and Paraganglioma: Why All Patients Should Be Offered Genetic TestingSemantic proximity Read ↗

Germline genetic variants in pheochromocytoma/paraganglioma: single-center experienceSemantic proximity Read ↗

Diagnosis and Management of Hereditary Phaeochromocytoma and Paraganglioma.Semantic proximity Read ↗

Pheochromocytoma: When to search a germline defect?Semantic proximity Read ↗

Clinical and molecular markers guide the genetics of pheochromocytoma and paraganglioma.Semantic proximity Read ↗

[Clinical and genetic characteristics and genotype-phenotype correlations of pheochromocytoma and paraganglioma in children and adolescents].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.